Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determine the Safety/Efficacy of Ticagrelor in Post-transplant Patients With Hepatic Artery Thrombosis (HAT)

NCT04946929 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04946929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04946929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determine the Safety/Efficacy of Ticagrelor in Post-transplant Patients With Hepatic Artery Thrombosis (HAT)
Lead sponsor
RenJi Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2021
Completion date
March 31, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic artery thrombosis, liver transplant; complications, pediatric disease